1993
DOI: 10.1152/ajpgi.1993.265.3.g418
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells

Abstract: The effect of nitric oxide (NO) donors on the release of mucus from a suspension of isolated gastric cells was investigated by using an enzyme-linked immunosorbent assay for rat gastric mucin. Isosorbide dinitrate (ISDN, 0.1-2 mM) produced a dose-related stimulation of mucus secretion, without affecting the viability of the isolated cells as determined by trypan blue exclusion or acid phosphatase release. In a comparable concentration range to that stimulating mucus release, ISDN elevated the guanosine 3',5'-c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
120
1
5

Year Published

1995
1995
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 141 publications
(142 citation statements)
references
References 0 publications
10
120
1
5
Order By: Relevance
“…Within the gastrointestinal tract, NO protects the stomach epithelium by stimulating mucosal and bicarbonate secretions [4,20,21]. NO may also confer protection to the mucosal layer by inhibiting gastric acid secretion and leukocyte adhesion to the epithelium [4,5,22,23].…”
Section: Introductionmentioning
confidence: 99%
“…Within the gastrointestinal tract, NO protects the stomach epithelium by stimulating mucosal and bicarbonate secretions [4,20,21]. NO may also confer protection to the mucosal layer by inhibiting gastric acid secretion and leukocyte adhesion to the epithelium [4,5,22,23].…”
Section: Introductionmentioning
confidence: 99%
“…mucosal blood flow (Pique et al, 1989), protection of gastric (MacNaughton et al, 1989) and intestinal ) mucosa, gastric mucus secretion (Brown et al, 1993) and intestinal electrolyte and fluid transport.…”
Section: Introductionmentioning
confidence: 99%
“…Of particular importance with regard to chemopreventive therapy are its effects on the gastrointestinal tract. The release of NO might compensate for NSAID-induced reductions in prostaglandin levels through the capacity of NO to increase mucosal blood circulation (12) and mucous release (13), and NO's properties of inhibiting neutrophil adherence and activation (14,15). Notably, NO-NSAIDs are associated with a significant reduction in renal toxicity as well (16,17).…”
mentioning
confidence: 99%